1. Burosumab in X-linked hypophosphatemia: a profile of its use in the USA

   • Katherine A. Lyseng-Williamson

   Adis Drug Q&A Open access 08 October 2018 Pages: 497 - 506

   

2. Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA

   • Young-A Heo

   Adis Drug Q&A Open access 05 October 2018 Pages: 507 - 512

3. Follow gentle cleansing practices to minimize the development of incontinence-associated dermatitis in the elderly

   • Adis Medical Writers

   Disease Management 06 September 2018 Pages: 513 - 516

   

4. First reports of adverse drug reactions

   Drug Reactions and Interactions 04 October 2018 Pages: 517 - 517

5. Overcome the challenges of drug administration in children by developing age-appropriate formulations

   • Adis Medical Writers

   Practical Issues and Updates 06 September 2018 Pages: 518 - 521

6. Knowledge of potency and formulations of topical corticosteroids among drug vendors in the Federal Capital Territory of Nigeria

   • Perpetua U. Ibekwe
   • Eshan B. Henshaw
   • Grace C. Okudo

   Original Research Article 07 August 2018 Pages: 522 - 527

   

7. Efficacy of adjuvant treatment with nebulized lidocaine in improving clinical and pulmonary function parameters of acute asthma attacks: a randomized double-blind clinical trial

   • Hassan Motamed
   • Mohammadreza Maleki Verki
   • Parviz Mozafari

   Original Research Article 11 September 2018 Pages: 528 - 533

   

8. Monitoring therapeutic colistin concentrations in critically ill patients admitted to a tertiary care hospital

   • Sriramulu Manivannan Vithunes
   • Sathiyanathan Priyanka
   • Veintramuthu Sankar

   Original Research Article 24 August 2018 Pages: 534 - 538